Action of BPTH and BPTH Fragments on Embryonic Bone in Vitro: Dissociation of the Cyclic AMP and Bone Resorbing Response

Overview

Journal Calcif Tissue Int

Specialty Pathology

Date 1983 Jan 1

PMID 6301659

Citations 10

Authors

M P HERRMANN-ERLEE

P J Nijweide

J M van der Meer

M A Ooms

Affiliations

Soon will be listed here.

Citing Articles

Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.

Greenfield E, Shaw S, Gornik S, Banks M J Clin Invest. 1995; 96(3):1238-44.

PMID: 7657797 PMC: 185744. DOI: 10.1172/JCI118157.

Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancy.

Dsouza S, Ibbotson K, Mundy G J Clin Invest. 1984; 74(3):1104-7.

PMID: 6470137 PMC: 425270. DOI: 10.1172/JCI111478.

Action of bPTH and bPTH fragments on embryonic bone in vitro: dissociation of the cyclic AMP and bone resorbing response.

HERRMANN-ERLEE M, Nijweide P, van der Meer J, Ooms M Calcif Tissue Int. 1983; 35(1):70-7.

PMID: 6301659 DOI: 10.1007/BF02405009.

Structural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic adenosine monophosphate and bone gamma-carboxyglutamic acid-containing protein from perfused rat hindquarters.

Calvo M, Fryer M, Laakso K, Nissenson R, Price P, Murray T J Clin Invest. 1985; 76(6):2348-54.

PMID: 3001148 PMC: 424371. DOI: 10.1172/JCI112246.

Hypercalcaemia of malignancy.

Kelly P, Eisman J Cancer Metastasis Rev. 1989; 8(1):23-52.

PMID: 2667784 DOI: 10.1007/BF00047056.

References

Marcus R, Orner F . Parathyroid hormone as a calcium ionophore in bone cells: tests of specificity. Calcif Tissue Int. 1980; 32(3):207-11. DOI: 10.1007/BF02408543. View

Peck W . Cyclic AMP as a second messenger in the skeletal actions of parathyroid hormone: a decade-old hypothesis. Calcif Tissue Int. 1979; 29(1):1-4. DOI: 10.1007/BF02408047. View

Rosenblatt M, Segre G, Tyler G, Shepard G, Nussbaum S, Potts Jr J . Identification of a receptor-binding region in parathyroid hormone. Endocrinology. 1980; 107(2):545-50. DOI: 10.1210/endo-107-2-545. View

LOWRY O, Passonneau J, HASSELBERGER F, Schulz D . EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN. J Biol Chem. 1964; 239:18-30. View

HERRMANN-ERLEE M, Nijweide P, van der Meer J, Ooms M . Action of bPTH and bPTH fragments on embryonic bone in vitro: dissociation of the cyclic AMP and bone resorbing response. Calcif Tissue Int. 1983; 35(1):70-7. DOI: 10.1007/BF02405009. View

Tregear G, Potts Jr J . Synthetic analogues of residues 1-34 of human parathyroid hormone: influence of residue number 1 on biological potency in vitro. Endocr Res Commun. 1975; 2(8):561-70. DOI: 10.3109/07435807509050679. View

Nussbaum S, Rosenblatt M, Potts Jr J . Parathyroid hormone . renal receptor interactions. Demonstration of two receptor-binding domains. J Biol Chem. 1980; 255(21):10183-7. View

Rosenblatt M, Callahan E, MAHAFFEY J, Pont A, Potts Jr J . Parathyroid hormone inhibitors. Design, synthesis, and biologic evaluation of hormone analogues. J Biol Chem. 1977; 252(16):5847-51. View

HERRMANN-ERLEE M, Meer JM vd . The effects of dibutyryl cyclic AMP, aminophylline and propranolol on PTE-induced bone resorption in vitro. Endocrinology. 1974; 94(2):424-34. DOI: 10.1210/endo-94-2-424. View

10.

HERRMANN-ERLEE M, van der Meer J, HEKKELMAN J . In vitro studies of the adenosine 3',5'-monophosphate (cAMP) response of embryonic rat calvaria to bovine parathyroid hormone-(1--84) [bPTH-(1--84)], BPTH-(1--34), and bPTH-(3--34) and the loss of cAMP responsiveness after prolonged incubation. Endocrinology. 1980; 106(6):2013-8. DOI: 10.1210/endo-106-6-2013. View

11.

Marcus R, Orner F . Cyclic AMP production in rat calvaria in vitro: interaction prostaglandins with parathyroid hormone. Endocrinology. 1977; 101(5):1570-8. DOI: 10.1210/endo-101-5-1570. View

12.

Peck W, KLAHR S . Cyclic nucleotides in bone and mineral metabolism. Adv Cyclic Nucleotide Res. 1979; 11:89-130. View

13.

Goltzman D, Goltzmann D, Peytremann A, Callahan E, Tregear G, Potts Jr J . Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues. J Biol Chem. 1975; 250(8):3199-203. View

14.

HERRMANN-ERLEE M, Gaillard P, HEKKELMAN J, Nijweide P . The effect of verapamil on the action of parathyroid hormone on embryonic bone in vitro. Eur J Pharmacol. 1977; 46(1):51-8. DOI: 10.1016/0014-2999(77)90143-1. View

15.

Goldring S, MAHAFFEY J, Rosenblatt M, Dayer J, Potts Jr J, Krane S . Parathyroid hormone inhibitors: comparison of biological activity in bone- and skin-derived tissue. J Clin Endocrinol Metab. 1979; 48(4):655-9. DOI: 10.1210/jcem-48-4-655. View

16.

Partridge N, Alcorn D, Michelangeli V, Kemp B, RYAN G, Martin T . Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology. 1981; 108(1):213-9. DOI: 10.1210/endo-108-1-213. View

17.

Nijweide P, van der Plas A, Scherft J . Biochemical and histological studies on various bone cell preparations. Calcif Tissue Int. 1981; 33(5):529-40. DOI: 10.1007/BF02409485. View

18.

Jackson J, Breen M, Chen C . Fluorometric titration of calcium. J Lab Clin Med. 1962; 60:700-8. View

19.

Segre G, Rosenblatt M, Reiner B, MAHAFFEY J, Potts Jr J . Characterization of parathyroid hormone receptors in canine renal cortical plasma membranes using a radioiodinated sulfur-free hormone analogue. Correlation of binding with adenylate cyclase activity. J Biol Chem. 1979; 254(15):6980-6. View

20.

Karsten U, WOLLENBERGER A . Improvements in the ethidium bromide method for direct fluorometric estimation of DNA and RNA in cell and tissue homogenates. Anal Biochem. 1977; 77(2):464-70. DOI: 10.1016/0003-2697(77)90259-7. View